|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
|
Vapotherm Issues Urgent Nationwide Recall Of All Vapotherm 2000i Respiratory Gas Humidification DevicesDate: 1/26/2006
Reason: Some of the devices have been found to contain the Ralstonia species of bacteria.
Distribution: Nationwide.
The Food and Drug Administration (FDA) released the following information: Vapotherm, Inc., Stevensville, Maryland, is initiating a nationwide recall of all Vapotherm 2000i Respiratory Gas Humidification devices. Some of these devices have been found to contain the Ralstonia species of bacteria. Ralstonia, as with any gram negative organism, may cause infection, sepsis and in most severe cases be life threatening. Health care practitioners should seek alternative respiratory gas humidification devices. Any health care facilities that have the Vapotherm 2000i device must return all devices to Vapotherm, Inc. Instructions for return are listed on our recall information website at http://www.vtherm.com/recall or by calling Vapotherm, Inc. at 1-866-827-6843. The "Vapotherm 2000i" label is located on the front of the device on the lower right hand corner. If there is a question in identification of the product please contact Vapotherm for assistance. This device is used in both the home and in health care institutions for warming and humidifying breathing gases, such as oxygen, delivered by nasal cannula. The firm first learned that patients were colonized by the bacteria from a Pennsylvania hospital on August 17, 2005, and subsequently issued a voluntary recall of the Vapotherm 2000i on October 13, 2005. FDA has since been apprised of this action. At this time, the following information is known: There are numerous reports of Ralstonia colonization, including three reports of infection. The Vapotherm 2000i devices were distributed through specialty distributors in the U.S. and internationally. Consumers with questions regarding this recall may contact the company at 1-866-827-6843, or Kevin Thibodeau at 410-604-3977. Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch. Other Drugs / Medicines Recalls and Alerts of InterestDate: 6/12/2008 Reason: Limited lots of Carmeda-coated products were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS). Distribution: Nationwide Date: 6/12/2008 Reason: Taking AZASAN® instead of SOLODYN® presents a health hazard and safety risk to patients Date: 6/12/2008 Reason: it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil Distribution: Nationwide Date: 6/12/2008 Reason: Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS) Distribution: Nationwide Date: 6/16/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate Distribution: Nationwide Date: 6/12/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate |
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.








